Vertex Pharmaceuticals Incorporated
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionIeq Capital, Llc
Latest Disclosed Ownership27,175 shares
Latest Disclosed Value $ 12,134,754
Ieq Capital, Llc reports 20.65% increase in ownership of VRTX / Vertex Pharmaceuticals Incorporated

On May 14, 2026 - Ieq Capital, Llc filed a 13F-HR form disclosing ownership of 27,175 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $12,134,724 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 22,524 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of 20.65% during the quarter. The current value of the position is $12,142,605 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 27,175 4,651 20.65 12,135 18.83 0.0409
2026-02-13 2025-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 22,524 16,073 249.16 10,212 304.24 0.0306
2025-11-14 2025-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 6,451 -9,768 -60.23 2,527 -65.01 0.0077
2025-08-14 2025-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 16,219 -5,786 -26.29 7,220 -32.32 0.0442
2025-05-14 2025-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 22,005 3,782 20.75 10,668 45.38 0.0849
2025-02-03 2024-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 18,223 -4,358 -19.30 7,338 -30.12 0.0709
2024-11-14 2024-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 22,581 1,488 7.05 10,502 6.22 0.1288
2024-08-12 2024-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 21,093 1,877 9.77 9,887 23.08 0.1331
2024-05-09 2024-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 19,216 1,233 6.86 8,032 9.79 0.1154
2024-02-07 2023-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 17,983 500 2.86 7,317 20.35 0.1217
2023-11-06 2023-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 17,483 999 6.06 6,080 4.81 0.1237
2023-08-08 2023-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 16,484 1,638 11.03 5,801 24.01 0.1170
2023-05-02 2023-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 14,846 487 3.39 4,677 12.81 0.1085
2023-02-06 2022-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 14,359 840 6.21 4,146 5.93 0.1161
2022-11-04 2022-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 13,519 4,875 56.40 3,914 60.67 0.1074
2022-07-27 2022-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 8,644 1,601 22.73 2,436 32.54 0.0738
2022-04-26 2022-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 7,043 1,199 20.52 1,838 43.26 0.0438
2022-01-31 2021-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 5,844 2,209 60.77 1,283 94.69 0.0297
2021-11-09 2021-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,635 1,228 51.02 659 35.88 0.0175
2021-07-29 2021-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,407 -102 -4.07 485 -10.02 0.0143
2021-05-04 2021-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,509 2,509 539 0.0223
2021-02-03 2020-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -2,078 -100.00 0 -100.00
2020-11-03 2020-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,078 -113 -5.16 565 -11.16 0.0304
2020-07-31 2020-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,191 -13 -0.59 636 21.37 0.0413
2020-05-07 2020-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,204 688 45.38 524 57.83 0.0421
2020-02-11 2019-12-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 1,516 1,516 332 0.0291
2020-02-04 2019-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,045 269
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.